Navigation Links
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
Date:8/11/2008

The Study Will Correlate the Results of Rosetta Genomics' MicroRNA-Based CUP Assay With Diagnostic Work Conducted at M.D. Anderson Cancer Center Data on the Company's MicroRNA-Based CUP Assay and its High Sensitivity and Accuracy was Recently Published in the April Issue of Nature Biotechnology

REHOVOT, Israel and JERSEY CITY, New Jersey, August 11 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical validation study with The University of Texas M. D. Anderson Cancer Center (MDACC). The study will focus on Rosetta Genomics' microRNA-based test that identifies the primary site of cancer of unknown primary (CUP). The study will include one hundred patients who are diagnosed with CUP at MDACC, and who meet the eligibility criteria. Rosetta Genomics expects this test to be submitted for regulatory approval in the second half of 2008.

"The initiation of this validation study is an integral part of the commercialization roadmap for our diagnostic tests, as we advance them towards use in a clinical setting," said Amir Avniel, President and CEO of Rosetta Genomics. "We believe the initiation of this study for our CUP assay with a leading cancer research center such as M. D. Anderson attests to the critical unmet need this test addresses." CUP is a heterogeneous group of cancers that constitutes 3-5% of all cancers with a poor median survival of 6-10 months(1). Each year, approximately 70,000 patients in the United States are diagnosed with CUP. A patient is typically diagnosed with CUP only after undergoing a wide range of tests, including various imaging tests such as x-ray, CT, MRI, and PET, which often fail to identify the origin of the cancer.

Presently, the choice of treatment for metastatic cancer is largely dependent on the nature of the primary tumor. Patients with CUP pose a therapeutic dilemma and t
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
2. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
3. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
4. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
5. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
6. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...-GlobalTrends ,, http://www.reportlinker.com..., Widespreadavailabilityofgenericdrugs,emergence...acceleratedthepaceofgrowthinthepainmanagementmarke...uetoshapedemandforservices,drugsanddevices.Themark...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
(Date:11/24/2009)...-FirstCall/--QuestDiagnosticsIncorporated(NYSE: DG...nformationandservices,announcedthatitisscheduledto...ceinNewYorkCity.ThepresentationisscheduledforWedne...ringtheconference,thecompanywillreaffirmits2009gui...metoexceed18%ofrevenues,anddilutedearningspershare...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2New essays examine the use of fMRI to recognize deceit 48204 1New essays examine the use of fMRI to recognize deceit 48204 2Horse whisperers lion tamers not needed 3A Scientists find genetic regions that soothe savage beasts 8749 1Horse whisperers lion tamers not needed 3A Scientists find genetic regions that soothe savage beasts 8749 2HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 1HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 2HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University 12526 3
(Date:11/27/2009)...nprecedented medical, economic burdens, study pred...) -- The number of people with diabetes in the Uni...years, a new study predicts. , That would bring...th the disease, up from 23.7 million today. , , ... diabetes will triple, the study also warns, risin...
(Date:11/27/2009)... Voyant Health™ announced today that Spectr...s TraumaCad Enterprise orthopedic templating solut... (PRWEB) November 27, 2009...trum Health (Grand Rapids, Michigan) has licensed ...ution and its TraumaCad Extend workflow solution, ...
(Date:11/27/2009)... Specialist manufacturers who use medical load ce...ions of dollars by bringing in technology partner ...mbers of pro-active medical manufacturers are call...age of their projects, ensuring that progress will...r potentially outdated technology. , ...
(Date:11/26/2009)...RNewswire/--Withcoldandfluseasonuponus,it,smoreimp...eadofinfectionsandavoidillness. ,, "Weneedtobep...ansmittingillnessifwe,resick,"saidEileenFinerty,RN...torforinfectioncontrolandoccupationalhealthatHospi...alforSpecialSurgeryhasoneofthelowestinfectionrates...
(Date:11/26/2009)...the number of Americans living with diabetes will ...9 to 44.1 million in 2034. Over the same period, s...m $113 billion to $336 billion, even with no incre...d at the University of Chicago report in the Decem...ose with diabetes covered by Medicare will rise fr...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ease tuberculosis is on the march. Figures release...increase by 2 percent in number of TB cases over t...orld TB Day, which falls on the 24th of March, a... the actual numbers have fallen from 3,541 in 2005...
...hinese medical beliefs continue to have an impact ...ne Hom, a dental student at the Harvard School of ...dings today during the 85th General Session of the... Traditional Chinese Medicine (TCM) professionals,...
... claimed that the global tuberculosis (TB) epidemi...lared TB a public health emergency in 1993. // ...day, two days before the world TB day, says that ...cribed the development as a culmination of the sus...
...ed as a flight attendant. She started exercising t...g to her// she was very keen that she be agile and...or Tom Landry Fitness Center. Her exercise regimen...pine that Nicholson is an excellent example to fol...
...enter for Science in the Public Interest, says not... 15 years back. It is still unhealthy. Accord...n, for example, is loaded with about 40 percent mo...ories, 3,200 milligrams of sodium and 11 grams of ...
...iabetes say researchers. If you are a woman, it ca...cer. // Researchers from the Department of Sur... Hospital in Sweden, led by Dr. Par Stattin conduc...The research named the V?sterbotten Intervention...
Other Medicine News:Health News:TB Cases on the Rise 2Health News:Global Tuberculosis Epidemic Levelling Off - WHO 2Health News:Chinese-food Lovers, Beware 2Health News:Women – watch Your Fat and Sugar Intakes to Keep Cancer at Ba 2
Assetrac Location & Protection System
...-based and RFID-enabled location system that allow...nd utilization of resources throughout the periope...Trac collects patient information including locati...ht experience. This information is directed to bot...
RoamAlert Eco
awarix Enterprise Visibility Solutions for Healthcare
Medicine Products: